Spectral Medical (EDTXF) Stock Price, News & Analysis

Company Overview

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $0.37 to $0.37
• 50-Day Range: $0.40 to $0.50
• 52-Week Range: $0.27 to $0.55
• Volume: 12,500 shs
• Average Volume: 17,664 shs
• Market Capitalization: $104.65 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EDTXF Stock Analysis - Frequently Asked Questions

How have EDTXF shares performed this year?

Spectral Medical's stock was trading at $0.32 on January 1st, 2024. Since then, EDTXF shares have increased by 15.6% and is now trading at $0.37.
View the best growth stocks for 2024 here.

How do I buy shares of Spectral Medical?

Shares of EDTXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 11/22/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EDTXF
• Previous Symbol: OTCMKTS:DIAGF
• CUSIP: N/A
• CIK: N/A
• Web: www.spectraldx.com
• Phone: (416) 626-3233
• Fax: 416-626-7383
• Employees: 29
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-11,600,000.00
• Net Margins: -1,245.87%
• Pretax Margin: -964.32%
• Return on Equity: N/A
• Return on Assets: -370.99%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.60
• Quick Ratio: 0.59

Sales & Book Value

• Annual Sales: $1.18 million
• Price / Sales: 88.69
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.04) per share
• Price / Book: -9.25

Miscellaneous

• Outstanding Shares: 282,840,000
• Free Float: 278,573,000
• Market Cap: $104.65 million
• Optionable: Not Optionable
• Beta: 0.92